Skip to main content

Advertisement

SpringerLink
Log in

Role of tumor-associated macrophages in the progression of hepatocellular carcinoma

  • Review Article
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

Recent studies have shown that the tumor microenvironment plays an important role in cancer progression. Tumor-associated macrophages (TAMs), in particular, have been found to be associated with tumor progression. Macrophages have multiple biological roles, including antigen presentation, target cell cytotoxicity, removal of foreign bodies, tissue remodeling, regulation of inflammation, induction of immunity, thrombosis, and endocytosis. Recent immunological studies have identified two distinct states of polarized macrophage activation: the classically activated (M1) and the alternatively activated (M2) macrophage phenotypes. Bacterial moieties such as lipopolysaccharides and the Th1 cytokine interferon-γ polarize macrophages toward the M1 phenotype. The M2 polarization was discovered as a response to the Th2 cytokine interleukin-4. In general, M2 macrophages exert immunoregulatory activity, participate in polarized Th2 responses, and aid tumor progression. TAMs have recently been found to play an important role in hepatocellular carcinoma (HCC) progression. Based on the properties of TAMs, obtained from pathological examination of resected specimens, we have identified new therapeutic approaches, involving the targeting of TAMs with adjuvant therapy after hepatic resection for HCC. This review discusses the roles of TAM in HCC progression and the possibility of new therapies targeting TAMs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362:1907–17.

    Article  PubMed  Google Scholar 

  2. Shirabe K, Kanematsu T, Matsumata T, Adachi E, Akazawa K, Sugimachi K. Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy: univariate and multivariate analyses. Hepatology. 1991;14:802–5.

    Article  PubMed  CAS  Google Scholar 

  3. Yamashita Y, Morita K, Iguchi T, Tsujita E, Soejima Y, Taketomi A, et al. Surgical impacts of an en bloc resection of the diaphragm for hepatocellular carcinoma with gross diaphragmatic involvement. Surg Today. 2011;41:101–6.

    Article  PubMed  Google Scholar 

  4. Sakaguchi T, Suzuki S, Morita Y, Oishi K, Suzuki A, Fukumoto K, Inaba K, et al. Impact of the preoperative des-gamma-carboxy prothrombin level on prognosis after hepatectomy for hepatocellular carcinoma meeting the Milan criteria. Surg Today. 2010;40:638–45.

    Article  PubMed  Google Scholar 

  5. Taketomi A, Fukuhara T, Morita K, Kayashima H, Ninomiya M, Yamashita Y, et al. Improved results of a surgical resection for the recurrence of hepatocellular carcinoma after living donor liver transplantation. Ann Surg Oncol. 2010;17:2283–9.

    Article  PubMed  Google Scholar 

  6. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357:539–45.

    Article  PubMed  CAS  Google Scholar 

  7. de Visser KE, Eichten A, Coussens LM. Paradoxical roles of the immune system during cancer development. Nat Rev Cancer. 2006;6(1):24–37.

    Article  PubMed  Google Scholar 

  8. Bingle L, Brown NJ, Lewis CE. The role of tumor-associated macrophages in tumor progression: implications for new anticancer therapies. J Pathol. 2002;196:254–65.

    Article  PubMed  CAS  Google Scholar 

  9. Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer. 2004;4:71–8.

    Article  PubMed  CAS  Google Scholar 

  10. Lewis CE, Pollard JW. Distinct role of macrophages in different tumor microenvironments. Cancer Res. 2006;66:605–12.

    Article  PubMed  CAS  Google Scholar 

  11. Siveen KS, Kuttan G. Role of macrophages in tumor progression. Immunol Lett. 2009;123:97–102.

    Article  PubMed  CAS  Google Scholar 

  12. Stein M, Kehav S, Harris N, Gordon S. Interleukin 4 potentially enhances murine macrophage mannose receptor activity. J Exp Med. 1992;176:287–92.

    Article  PubMed  CAS  Google Scholar 

  13. Biswas SK, Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol. 2010;11(10):889–96.

    Article  PubMed  CAS  Google Scholar 

  14. Martiner FO, Gordon S, Locati M, Manotovani A. Transcriptional profiling of the human monocytes to macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol. 2006;177:7303–11.

    Google Scholar 

  15. Cossens LM, Webs Z. Inflammation and cancer. Nature (Lond). 2002;420:860–7.

    Article  Google Scholar 

  16. Mantovani A. Tumour-associated macrophages in neoplastic progression: a paradigm for the in vivo function of chemokines. Lab Invest. 1994;71:5–16.

    PubMed  CAS  Google Scholar 

  17. Leung SY, Wong MP, Chung LP, Chan ASY, Yuen ST. Monocyte chemoattractant protein-1 expression and macrophage infiltration in gliomas. Acta Neuropathol. 1997;93:518–27.

    Article  PubMed  CAS  Google Scholar 

  18. Sato K, Kuratsu J, Takeshima H, Yoshimura T, Ushio Y. Expression of monocyte chemoattractant protein-1 on meningioma. J Neurosurg. 1995;82:874.

    Article  PubMed  CAS  Google Scholar 

  19. Negus RP, Stamp GW, Relf MG, Burke F, Malik ST, Bernasconi S, et al. The detection and location of monocyte chemoattractant protein-1 in human ovarian cancer. J Clin Invest. 1995;95:2391–6.

    Article  PubMed  CAS  Google Scholar 

  20. Riethdorf L, Riethdorf S, Gutzlaff K, Prall F, Loning T. Differential expression of the monocyte chemoattractant protein-1 gene in human papillomavirus-16-infected squamous intraepithelial lesions and squamous cell carcinomas of the cervix uteri. Am J Pathol. 1996;149:1469–76.

    PubMed  CAS  Google Scholar 

  21. Murdock C, Giannouds A, Lewis CE. Mechanisms regulating the recruitment of macrophages into hypoxic areas of timorous and ischemic tissues. Blood. 2004;104:2224–34.

    Article  Google Scholar 

  22. Zhu XD, Zhang JB, Zhuang PY, Zhu HG, Zhang W, Xiong YQ, et al. High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma. J Clin Oncol. 2008;26:2707–16.

    Article  PubMed  Google Scholar 

  23. Jia JB, Wang WQ, Sun HC, Zhu XD, Liu L, Zhuang PY, et al. High expression of macrophage colony-stimulatory factor-1 receptor in peritumoral liver tissue is associated with poor outcome in hepatocellular carcinoma after curative resection. Oncologist. 2010;15:732–43.

    Article  PubMed  CAS  Google Scholar 

  24. Shen X, Li N, Li H, Zhang T, Wang F, Li Q. Increased prevalence of regulatory T cells in the tumor microenvironment and its correlation with TNM stage of hepatocellular carcinoma. J Cancer Res Clin Oncol. 2010;136(11):1745–54.

    Article  PubMed  CAS  Google Scholar 

  25. Takai H, Kato A, Watanabe T, Matsubara K, Suzuki M, Kataoka H. The expression profile of glypican-3 and its relation to macrophage population in human hepatocellular carcinoma. Liver Int. 2009;29(7):1056–64.

    Article  PubMed  CAS  Google Scholar 

  26. Takai H, Ashihara M, Ishiguro T, Terashima H, Watanabe T, Kato A, et al. Involvement of glypican-3 in the recruitment of M2-polarized tumor-associated macrophages in hepatocellular carcinoma. Cancer Biol Ther. 2009;8:2329–38.

    PubMed  CAS  Google Scholar 

  27. Biswas SK, Lopez-Collazo E. Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trend Immunol. 2009;30:475–87.

    Article  CAS  Google Scholar 

  28. Porta C, Rimoldi M, Raes G, Brys L, Ghezzi P, Di Liberto D, et al. Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear nuclear κB. Proc Natl Acad Sci USA. 2009;106:14978–83.

    Article  PubMed  CAS  Google Scholar 

  29. Yuen MF, Hughes RD, Heneghan MA, Langley PG, Norris S. Expression of Fas antigen (CD95) in peripheral blood lymphocytes and liver-infiltrating, cytotoxic lymphocytes in patients with hepatocellular carcinoma. Cancer (Phila). 2001;92:2136–41.

    Article  CAS  Google Scholar 

  30. Unitt E, Rushbrook SM, Marshall A, Davies S, Gibbs P, Morris LS, et al. Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells. Hepatology. 2005;41:722–30.

    Article  PubMed  CAS  Google Scholar 

  31. Zhou J, Ding T, Pan W, Zhu LY, Li L, Zheng L. Increased intratumoral regulatory T cells are related to intratumoral macrophages and poor prognosis in hepatocellular carcinoma. Int J Cancer. 2009;125:1640–8.

    Article  PubMed  CAS  Google Scholar 

  32. Wu K, Kryczek I, Chen L, Zou W, Welling TH. Kupffer cell suppression of CD8+ T cells in human hepatocellular carcinoma is mediated by B7–H1/programmed death-1 interactions. Cancer Res. 2009;69(20):8067–75.

    Article  PubMed  CAS  Google Scholar 

  33. Kuang DM, Zhao Q, Peng C, Xu J, Zhang JP, Wu C, Zheng L. Activated monocytes in peritumoral stroma foster immune privilege and disease progression through PD-L1. J Exp Med. 2009;206(6):1327–37.

    Article  PubMed  CAS  Google Scholar 

  34. Ju MJ, Qiu SJ, Fan J, Xiao YS, Gao Q, Zhou J, et al. Peritumoral activated hepatic stellate cells predict poor clinical outcome in hepatocellular carcinoma after curative resection. Am J Clin Pathol. 2009;131:498–510.

    Article  PubMed  CAS  Google Scholar 

  35. Charles KA, Kulbe H, Soper R, Escorcio-Correia M, Lawrence T, Schultheis A, et al. The tumor-promoting actions of TNF-α involve TNFR1 and IL-17 in ovarian cancer in mice and humans. J Clin Invest. 2009;119:3011–23.

    Article  PubMed  CAS  Google Scholar 

  36. Zhang JP, Yan J, Xu J, Pang XH, Chen MS, Li L, et al. Increased intratumoral IL-17 producing cells correlates with poor survival in hepatocellular carcinoma patients. J Hepatol. 2009;50:980–9.

    Article  PubMed  CAS  Google Scholar 

  37. Kuang DM, Peng C, Zhao Q, Zhao Q, Wu Y, Zhu LY, et al. Tumor-activated monocytes promote expansion of IL-17-producing CD8+ T cells in hepatocellular carcinoma patients. J Immunol. 2010;185:1544–9.

    Article  PubMed  CAS  Google Scholar 

  38. Kuang DM, Peng C, Wu Y, Chen MS, Zheng L. Activated monocytes in peritumoral stroma of hepatocellular carcinoma promote expansion of memory T helper 17 cells. Hepatology. 2010;51:154–64.

    Article  PubMed  CAS  Google Scholar 

  39. Gorelik E, Wiltrout RH, Brunda MJ, Holden HT, Herberman RB. Augmentation of metastasis formation by thioglycollate-elicited macrophages. Int J Cancer. 1982;29:575–81.

    Article  PubMed  CAS  Google Scholar 

  40. Rolny C, Capparuccia L, Casazza A, Mazzone M, Vallario A, Cignetti A, et al. The tumor suppressor semaphorin 3B triggers a prometastatic program mediated by interleukin 8 and the tumor microenvironment. J Exp Med. 2008;205(5):1155–71.

    Article  PubMed  CAS  Google Scholar 

  41. Hsia CY, Huo TI, Chiang SY, Lu MF, Sun CL, Wu JC, et al. Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma. Eur J Surg Oncol. 2007;33(2):208–12.

    Article  PubMed  Google Scholar 

  42. Liu Y, Fuchs J, Li C, Lin J. IL-6, a risk factor for hepatocellular carcinoma: FLLL32 inhibits IL-6-induced STAT3 phosphorylation in human hepatocellular cancer cells. Cell Cycle. 2010;9(17):3423–7.

    Article  PubMed  CAS  Google Scholar 

  43. Ojalvo LS, Whittaker CA, Condeelis JS, Pollard JW. Gene expression analysis of macrophages that facilitate tumor invasion supports a role for Wnt-signaling in mediating their activity in primary mammary tumors. J Immunol. 2010;184(2):702–12.

    Article  PubMed  CAS  Google Scholar 

  44. Condeelis J, Segall JE. Intravital imaging of cell movement in tumours. Nat Rev Cancer. 2003;3(12):921–30.

    Article  PubMed  CAS  Google Scholar 

  45. Murdoch C, Giannoudis A, Lewis CE. Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood. 2004;104(8):2224–34.

    Article  PubMed  CAS  Google Scholar 

  46. Peng SH, Deng H, Yang JF, Xie PP, Li C, Li H, et al. Significance and relationship between infiltrating inflammatory cell and tumor angiogenesis in hepatocellular carcinoma tissues. World J Gastroenterol. 2005;11:6521–4.

    PubMed  Google Scholar 

  47. Hotchkiss KA, Ashton AW, Klein RS, Lenzi ML, Zhu GH, Schwartz EL. Mechanisms by which tumor cells and monocytes expressing the angiogenic factor thymidine phosphorylase mediate human endothelial cell migration. Cancer Res. 2003;63(2):527–33.

    PubMed  CAS  Google Scholar 

  48. Marconi C, Bianchini F, Mannini A, Mugnai G, Ruggieri S, Calorini L. Tumoral and macrophage uPAR and MMP-9 contribute to the invasiveness of B16 murine melanoma cells. Clin Exp Metastasis. 2008;25(3):225–31.

    Article  PubMed  CAS  Google Scholar 

  49. Naylor MS, Stamp GW, Davies BD, Balkwill FR. Expression and activities of MMPs and their regulators in ovarian cancer. Int J Cancer. 1994;58:50–6.

    Article  PubMed  CAS  Google Scholar 

  50. Ding W, You H, Dang H, LeBlanc F, Galicia V, Lu SC, et al. Epithelial-to-mesenchymal transition of murine liver tumor cells promotes invasion. Hepatology. 2010;52(3):945–53.

    Article  PubMed  CAS  Google Scholar 

  51. van Zijl F, Mair M, Csiszar A, Schneller D, Zulehner G, Huber H, et al. Hepatic tumor-stroma crosstalk guides epithelial to mesenchymal transition at the tumor edge. Oncogene. 2009;28(45):4022–33.

    Article  PubMed  Google Scholar 

  52. Hotz B, Visekruna A, Buhr HJ, Hotz HG. Beyond epithelial to mesenchymal transition: a novel role for the transcription factor snail in inflammation and wound healing. J Gastrointest Surg. 2010;14:388–97.

    Article  PubMed  Google Scholar 

  53. Tang Yi, Kitisin K, Jogunoori W, Li C, Deng CX, Mueller SC, et al. Progenitor/stem cell give rise to liver cancer due to aberrant TGF-β and IL-6 signaling. Proc Natl Acad Sci USA. 2008;105(7):2445–50.

    Article  PubMed  CAS  Google Scholar 

  54. Werno C, Menrad H, Weigert A, Dehne N, Goerdt S, Schledzewski K, et al. Knockout of HIF-1α in tumor-associated macrophages enhances M2 polarization and attenuates their pro-angiogenic responses. Carcinogenesis (Oxf). 2010;31(10):1863–72.

    Article  CAS  Google Scholar 

  55. Ding T, Xu J, Wang F, Shi M, Zhang Y, Li SP, et al. High tumor-infiltrating macrophage density predicts poor prognosis in patients with primary hepatocellular carcinoma after resection. Hum Pathol. 2009;40:381–9.

    Article  PubMed  CAS  Google Scholar 

  56. Li YW, Qiu SJ, Fan J, Gao Q, Zhou J, Xiao YS, et al. Tumor-infiltrating macrophages can predict favorable prognosis in hepatocellular carcinoma after resection. J Cancer Res Clin Oncol. 2009;135:439–49.

    Article  PubMed  Google Scholar 

  57. Zhang W, Zhu XD, Sun HC, Xiong YQ, Zhuang PY, Xu HX, et al. Depletion of tumor-associated macrophages enhances the effect of sorafenib in metastatic liver cancer models by antimetastatic and antiangiogenic effects. Clin Cancer Res. 2010;16(13):3420–30.

    Article  PubMed  CAS  Google Scholar 

  58. Vicari AP, Chiodoni C, Vaure C, Aït-Yahia S, Dercamp C, Matsos F, et al. Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibody. J Exp Med. 2002;196(4):541–9.

    Article  PubMed  CAS  Google Scholar 

  59. Luo Y, Zhou H, Krueger J, Kaplan C, Lee SH, Dolman C, et al. Targeting tumor-associated macrophages as a novel strategy against breast cancer. J Clin Invest. 2006;116(8):2132–41.

    Article  PubMed  CAS  Google Scholar 

  60. Roland CL, Dineen SP, Lynn KD, Sullivan LA, Dellinger MT, Sadegh L, et al. Inhibition of vascular endothelial growth factor reduces angiogenesis and modulates immune cell infiltration of orthotopic breast cancer xenografts. Mol Cancer Ther. 2009;8(7):1761–71.

    Article  PubMed  CAS  Google Scholar 

  61. Kakinoki K, Nakamoto Y, Kagaya T, Tsuchiyama T, Sakai Y, Nakahama T, et al. Prevention of intrahepatic metastasis of liver cancer by suicide gene therapy and chemokine ligand 2/monocyte chemoattractant protein-1 delivery in mice. J Gene Med. 2010;12:1002–13.

    Article  PubMed  CAS  Google Scholar 

  62. Tsuchiyama T, Nakamoto Y, Sakai Y, Mukaida N, Kaneko S. Optimal amount of monocyte chemoattractant protein-1 enhances antitumor effects of suicide gene therapy against hepatocellular carcinoma by M1 macrophage activation. Cancer Sci. 2008;99:2075–82.

    Article  PubMed  CAS  Google Scholar 

  63. Gao Q, Wang XY, Qiu SJ, Yamato I, Sho M, Nakajima Y, et al. Overexpression of PD-L1 significantly associated with tumor aggressiveness and postoperative recurrence in human hepatocellular carcinoma. Clin Cancer Res. 2009;15(3):971–9.

    Article  PubMed  CAS  Google Scholar 

  64. Brahmer JR, Drake CG, Wollner I, Powderly JD, Picus J, Sharfman WH, et al. Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates. J Clin Oncol. 2010;28(19):3167–75.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

The authors have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan

    Ken Shirabe, Yohei Mano, Jun Muto, Rumi Matono, Takashi Motomura, Takeo Toshima, Kazuki Takeishi, Hidekaki Uchiyama, Tomoharu Yoshizumi, Akinobu Taketomi, Masaru Morita, Shunichi Tsujitani & Yoshihiko Maehara

  2. Department of Gastroenterological Surgery, National Kyushu Cancer Center, Fukuoka, Japan

    Yoshihisa Sakaguchi

Authors
  1. Ken Shirabe
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yohei Mano
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jun Muto
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rumi Matono
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Takashi Motomura
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Takeo Toshima
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Kazuki Takeishi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Hidekaki Uchiyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Tomoharu Yoshizumi
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Akinobu Taketomi
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Masaru Morita
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Shunichi Tsujitani
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Yoshihisa Sakaguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Yoshihiko Maehara
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ken Shirabe.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shirabe, K., Mano, Y., Muto, J. et al. Role of tumor-associated macrophages in the progression of hepatocellular carcinoma. Surg Today 42, 1–7 (2012). https://doi.org/10.1007/s00595-011-0058-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00595-011-0058-8

Keywords

Search

Navigation